Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors
Open Access
- 5 January 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 106 (3), 553-561
- https://doi.org/10.1038/bjc.2011.568
Abstract
The incidence of malignant melanoma is increasing faster than that for any other cancer. Histological examination of skin excision biopsies remains the standard method for melanoma diagnosis and prognosis. Significant morphological overlap between benign and malignant lesions complicates diagnosis, and tumour thickness is not always an accurate predictor of prognosis. To identify improved molecular markers to support histological examination, we used microarray analysis of formalin-fixed and paraffin-embedded samples from different stages of melanomagenesis to identify differentially expressed microRNAs (miRNAs). Differential expression was validated by qRT–PCR, and functional studies were carried out after transfection of miRNA precursors or inhibitors into melanoma cells to modulate miRNA expression. In all, 20 miRNAs showed highly significant differential expression between benign naevi and either primary or metastatic melanomas, the majority being downregulated in melanoma, whereas only 2 miRNAs, namely miR-203 and miR-205, were differentially expressed between primary and metastatic melanomas. In functional in vitro assays, overexpression of miR-200c and miR-205 inhibited anchorage-independent colony formation and overexpression of miR-211 inhibited both anchorage-independent colony formation and invasion. We have identified a series of differentially expressed miRNAs that could be useful as diagnostic or prognostic markers for melanoma and have shown that three miRNAs (namely miR-200c, miR-205 and miR-211) act as tumour suppressors.Keywords
This publication has 40 references indexed in Scilit:
- miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesionsBritish Journal of Cancer, 2011
- miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 ProteinPublished by Elsevier BV ,2011
- Melanoma cell invasiveness is regulated by miR‐211 suppression of the BRN2 transcription factorPigment Cell & Melanoma Research, 2011
- Intronic miR-211 Assumes the Tumor Suppressive Function of Its Host Gene in MelanomaMolecular Cell, 2010
- The Regulation of miRNA-211 Expression and Its Role in Melanoma Cell InvasivenessPLOS ONE, 2010
- Cellular senescence in naevi and immortalisation in melanoma: a role for p16?British Journal of Cancer, 2006
- Molecular diagnostics in melanomaJournal of the American Academy of Dermatology, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging SystemJournal of Clinical Oncology, 2001
- The misdiagnosis of malignant melanomaJournal of the American Academy of Dermatology, 1999